Details of the Drug Reposition

General Information of This Drug (ID: DMT0NTL)

Drug Name
BI-695500   DMT0NTL
Synonyms Rituximab biosimilar

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Phase 3 [1]
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Phase 3 [2]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Phase 3 [2]
Rheumatoid arthritis DISTSB4J FA20 Phase 3 [3]
------------------------------------------------------------------------------------
1 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Clinical trial [2]
------------------------------------------------------------------------------------
1 Application submitted Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diffuse large B-cell lymphoma DISSACK3 2A81 Application submitted [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)